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Abstract
Background: As part of the ongoing Collaborative Study of the Genetics of Alcoholism, we 
performed a longitudinal study of a high risk cohort of adolescents/young adults from families 
with a proband with an alcohol use disorder, along with a comparison group of age-matched 
controls. The intent was to compare the development of alcohol problems in subjects at risk with 
and without comorbid externalizing and internalizing psychiatric disorders.
Methods: Subjects (N = 3286) were assessed with a structured psychiatric interview at 2 year 
intervals over 10 years (2004–2017). The age range at baseline was 12–21.
Results: Subjects with externalizing disorders (with or without accompanying internalizing 
disorders) were at increased risk for the onset of an alcohol use disorder during the observation 
period. Subjects with internalizing disorders were at greater risk than those without comorbid 
disorders for onset of a moderate or severe alcohol use disorder. The statistical effect of comorbid 
disorders was greater in subjects with more severe alcohol use disorders. The developmental 
trajectory of drinking milestones and alcohol use disorders was also accelerated in those with more 
severe disorders.
Conclusions: These results may be useful for counseling of subjects at risk who present for 
clinical care, especially those subjects manifesting externalizing and internalizing disorders in the 
context of a positive family history of an alcohol use disorder. We confirm and extend findings that 
drinking problems in subjects at greatest risk will begin in early adolescence.
Keywords
alcohol use disorders; high risk studies; family studies; externalizing disorders; internalizing 
disorders
INTRODUCTION
Alcohol problems typically develop in late adolescence and early adulthood, though they can 
manifest at any time during adult life. Early age at first drink has been shown in many 
analyses to be a powerful predictor of an alcohol use disorder (AUD) (see review in [1] 
Deutsch et al., 2013). Family history of alcohol dependence is known to increase risk by at 
least two fold [2](Nurnberger et al., 2004). Males are more likely than females to develop 
alcohol use disorders ([3] Hasin et al., 2007; [4] Delker et al., 2016; [5] Vasilenko et al., 
2017), and this is true within families of alcohol-dependent probands as well as the general 
population ([2] Nurnberger et al., 2004). Recent data have shown that, in the US, African- 
Americans (AA) are less likely to develop an AUD than European- Americans (EA) ([6] 
Kessler et al., 1994; [7] Smith et al., 2006; [8] Huang et al., 2006; [9] Grant et al., 2015) 
though analysis over different age groups suggests that a different developmental course 
may characterize AUDs in African-Americans, with relatively later onset of disorders in 
Nurnberger et al. Page 2
J Psychiatr Brain Sci. Author manuscript; available in PMC 2019 December 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
comparison to EA groups ([10] Grant et al., 2012; [5] Vasilenko et al., 2017; [11] Liu and 
Mulia, 2018). It must be borne in mind that these rates are a moving target and there is 
evidence for relative increases of AUD in women and AA subjects compared to EA males 
over recent years ([12] Grant et al., 2017).
There is also a known risk relationship between other psychiatric disorders and alcohol use 
disorders. Persons with a mood disorder (especially bipolar disorder) have an increased 
lifetime risk for an alcohol use disorder, as compared with persons without mood disorders 
([13] Glantz et al., 2009). The increased risk for a substance use disorder (alcohol or drugs) 
following onset of a mood disorder is perhaps most precisely demonstrated by [14] Plana-
Ripoll et al. 2019, using a study of the Danish population that showed a cumulative risk of 
20% for men and 10% for women for an SUD during the fifteen years following the onset of 
a mood disorder. This represents a hazard ratio of ~5 for a disorder severe enough to come to 
clinical attention. Adolescents with a mood disorder are at increased risk for onset of alcohol 
problems ([15] Kessler et al., 2012; [16] Boschloo et al., 2013) and vice versa ([17] Kandel 
et al., 1999). Mood disorder may be associated with the course of alcohol problems as well 
as onset ([18] Crum et al., 2018). Scores on an internalizing scale were correlated with risk 
for alcohol and other drug use disorders in a prior analysis of the Collaborative Study on the 
Genetics of Alcoholism (COGA) subjects ([19] Acion et al., 2019).
There is an extensive literature supporting the relationship of externalizing disorders to 
subsequent development of AUDs and this has formed the basis of certain typologies of 
AUD, including Types 1 and 2 ([20] Cloninger, 1987) and Types A and B ([21] Babor et al., 
1992). Type 2 subjects are characterized by high novelty seeking, low harm avoidance, and 
low reward dependence ([20] Cloninger, 1987). They are more likely to be diagnosed with 
antisocial personality disorder and less likely to be able to abstain from alcohol. Type B 
subjects are more likely to have a history of childhood aggression and conduct disorder and 
less likely to have a sustained response to treatment in comparison to Type A subjects ([21] 
Babor et al., 1992). More recent studies also emphasize the role of externalizing disorders, 
such as conduct disorder and attention deficit hyperactivity disorder in increasing the risk for 
alcohol problems ([22] Kuperman et al., 2001; [23] Bucholz et al., 2017; [24] Groenman et 
al., 2017). Cannabis and tobacco use are also associated with increased risk for concomitant 
alcohol problems ([23] Bucholz et al., 2017).
We studied a sample at risk for the development of alcohol use disorder on the basis of 
family history. Initial assessment was done on all subjects in the age range 12–21. These 
subjects have been followed over time with assessments every two years for up to 10 years. 
The present report evaluates the relationship of comorbid externalizing and internalizing 
disorders to age of onset of an AUD in a group of adolescents/young adults at high risk for 
AUDs. We also compare the onset of two alcohol milestones (age of first drink, age of first 
regular drinking) in groups divided by AUD severity. We hypothesized that persons 
developing AUDs following the onset of externalizing and internalizing disorders would 
show earlier onset than those without those baseline disorders. We also hypothesized that 
more severe AUDs would show an earlier onset of alcohol-related developmental milestones 
such as age of first drink and age of first regular drinking. The present report is one of the 
first we are aware of that tracks the development of AUDs in the context of multiple 
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comorbid disorders in a high risk group, and it shows that some subjects are at great risk for 
alcohol problems in very early adolescence.
METHODS
Our subjects were participants in the adolescent to young adult Prospective sample of 
COGA (N = 3286). The COGA study started in 1989 and families were recruited between 
1989 and 1995. Each family was recruited through a proband with an alcohol use disorder 
(at that time [25] DSMIII-R and [26] Feighner), targeting successive admissions to treatment 
facilities. There was a family size requirement (at least two living first-degree relatives) with 
the idea of prioritizing larger families. All first-degree relatives were interviewed and 
families were extended through affected subjects (i.e., the identification of an affected uncle 
of the proband would then lead to invitations for interview of that uncle’s family members). 
The subjects in the present study were offspring of the proband (or in some cases second-
degree relatives). The response rate for recruitment was about 70% or more (with some 
inter-site variation). More information about the COGA study may be found in [23] Bucholz 
et al., 2017 and [27] Reich et al., 1998. All offspring in the age range (12–21) at the start of 
follow-up (2006–2007) were included. Offspring reaching the age of 12 during the course of 
the study (2006–2019) were also included. Subjects were interviewed at two-year intervals 
with the Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA-IV) 
interview [28] Bucholz et al., 1994. The mean age at first interview was 16.1 (3.3 SD) and 
the mean age at last interview 23.1 (5.0). Subjects had an average of 4.0 interviews (1.7). 
50.9% were female, 64.9% were EA and 30.9% AA. Ethnicity was assigned based on 
genotypic data, or by self-report if genotypes were not available. Subjects were members of 
a case family (proband with alcohol dependence −86.7% of subjects) or a comparison family 
(families recruited from medical or dental clinics or motor vehicle records with no selection 
for presence or absence of psychopathology). Non-drinkers were not excluded from the 
sample. The study was approved by The Indiana University Institutional Review Board 
(IRB) (project code: 1011004039R009, October 12, 2018). Written informed consent for the 
research was obtained from all participants in the study.
All subjects in the study were invited to participate in interviews at two-year intervals. 
Detailed information on participation is provided in [23] Bucholz et al., 2017. Information 
on all available interviews for each subject was combined in the present analysis with age of 
onset assigned according to the earliest description of psychopathology and a judgment of 
severity based on the time when the most symptoms were described. Every subject with at 
least one complete interview was included in the analysis.
DSM-IV [29] diagnoses for all disorders were made algorithmically from SSAGA 
information. However for these analyses we also generated a DSM-5 [30] diagnosis for 
AUD in the following way. Individual alcohol symptoms were queried, starting with 
symptoms of DSM-IV alcohol dependence and alcohol abuse, adding craving and 
subtracting legal problems related to alcohol. Onset and offset of each symptom was 
recorded, making it possible to cluster symptoms that occurred by age. Thus the analyses 
presented here use DSM-5 AUD as an outcome variable while all other disorders are 
diagnosed by DSM-IV.
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Diagnoses of externalizing and internalizing disorders at the baseline interview were also 
made algorithmically from the SSAGA using DSM-IV. Externalizing disorders included any 
of the following: ADHD, conduct disorder/antisocial personality disorder, oppositional 
defiant disorder, drug use disorder (including marijuana but not alcohol or tobacco). 
Internalizing disorders included major depression, panic disorder, obsessive-compulsive 
disorder, social phobia, and agoraphobia. Age of onset was determined for all comorbid 
disorders based on the SSAGA-IV.
Subjects were divided into groups based on whether they had an externalizing disorder or an 
internalizing disorder at the time of the baseline interview. The groups were: Externalizing, 
Internalizing, Both, or Neither. Alcohol use disorder diagnosis was then assessed at each 
interview period, using the DSM 5 distinctions for Mild AUD (2–3 symptoms), Moderate 
AUD (4–5 symptoms), and Severe AUD (6 or more symptoms. The age of onset was defined 
as the first age when the required number of symptoms occurred during the same year. If 
two interviews performed on the same subject at different times provided divergent estimates 
of age of onset, the earliest age was taken as correct. Subjects were stratified into mutually 
exclusive categories based on the most severe AUD diagnosis they received during any part 
of the follow-up period (i.e., subjects with severe AUD were not counted in the Mild or 
Moderate AUD categories, though they may have aged through a time when they would 
have qualified for one or both of those diagnoses). Subjects with age of onset of AUD prior 
to age of onset of internalizing/externalizing disorders were excluded from analysis.
We also performed a sensitivity analysis (for model dependence) in which all subjects with 
externalizing (with or without internalizing) were compared with all subjects without 
externalizing; likewise subjects with internalizing (with or without externalizing) were 
compared with all subjects without internalizing (see Supplementary materials). An 
externalizing-internalizing interaction term was included in this analysis.
Statistical Methods
A Cox proportional hazards model was used to test the relationship of baseline externalizing 
or internalizing diagnoses to later onset of an AUD. All Cox model analyses were adjusted 
for sex, ethnicity, family membership, and case/comparison status. Survival curves were 
estimated by Kaplan-Meier plots. Ages of onset for alcohol milestones were compared using 
ANOVA and t-test.
RESULTS
Overall, 43.0% of the sample met criteria for a diagnosis of either Mild, Moderate, or Severe 
AUD by the end of the observation period (1416/3286; Table 1).
At the time of the baseline interview, 982/3286 subjects had an externalizing diagnosis 
(29.9%); 140/3286 subjects had an internalizing diagnosis (4.3%), 286 had both (8.7%) and 
1878 had neither (57.2%) (Table 1). All covariates (sex, ethnicity, family type) had 
significant relationships to age of onset in subjects with either mild, moderate, or severe 
AUD (Table 2). The association of any comorbid disorder and presence of Alcohol Use 
Disorder was significant overall (chi-square p-value < 0.0001), and there was a significant 
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effect of comorbidity on age of onset as well (p < 0.001 for each type of AUD, Figure 1a–c). 
Among subjects with an externalizing disorder only at baseline, 515/982 (52.4%) had some 
type of AUD during the follow-up period. Among subjects with an internalizing disorder 
only at baseline 66/140 (47.1%) had an AUD. Among subjects with both externalizing and 
internalizing, 182/286(63.6%) had an AUD. In comparison, subjects with neither type of 
disorder had an AUD rate of 34.7% (653/1878).
Figure 1 shows onset of alcohol use disorders (AUDs) in subjects stratified by initial 
diagnoses of Externalizing disorder, Internalizing disorder, Both, or Neither. Figures 1a–c 
show onset of mild, moderate, and severe AUDs respectively. For each type of AUD, the 
relationship with comorbid disorders is significant by Log-rank test (p < 0.001) and Cox 
Proportional Hazards (p < 0.001).
Age of onset comparisons are shown in Kaplan-Meier Plots (Figure 1a–c). Each of these 
shows significant effects of comorbidity by Log-rank Test (p < 0.001 for each). The plots do 
not include a covariate effect but we have also achieved similar results by the Cox model 
adjusting for covariate effects (p < 0.001 for each; Table 2). The statistical effect of 
comorbidity is generally greatest in the development of Severe AUD and least in Mild AUD 
based on the hazard ratios in the different comorbidity types (Table 2). The three groups are 
significantly different from each other in the strength of the comorbidity effect (Severe vs 
Moderate, p < 0.001; Severe vs Mild, p < 0.001; Moderate vs Mild, p < 0.001).
The sensitivity analysis (Supplementary Table S1) showed a clear effect of externalizing on 
age of onset in mild AUD, moderate AUD, and severe AUD (p < 0.001 for each). For 
internalizing, there was an effect in moderate AUD (p < 0.011) and severe AUD (p < 0.001). 
No statistical interaction was seen between the effect of externalizing and the effect of 
internalizing.
Age of onset distributions are presented for Mild AUD (Figure 2a), Moderate AUD (Figure 
2b), and Severe AUD (Figure 2c). The distributions include drinking milestones (first drink, 
first regular drinking) as well as onset ages for the diagnoses of Mild AUD (Figure 2a–c), 
Moderate AUD (Figure 2b,c) and Severe AUD (Figure 2c only). As noted above, the study 
samples are independent of each other for analytic purposes, and are classified according to 
the most severe disorder that the subject met criteria for during the observation period.
Figure 2 shows drinking milestones in subjects who developed an alcohol use disorder.
Figure 2a–c show mean, median, interquartile range, and outliers for subjects with mild (N = 
684), moderate (N = 415) and severe (N = 317) alcohol use disorder. Subjects are classified 
in a cohort according to the most severe form of disorder they manifested during the 
observation period. In Figure 2b milestones for the moderate group include the age when 
they would have been first classified as showing a mild AUD. In Figure 2c milestones for the 
severe group include the ages when they would have been first classified as showing a mild 
or moderate AUD.
We used ANOVA and i-test to detect the correlation between the onset of drinking 
milestones in the four diagnostic groups. The mean age of first drink progresses from 16.2 in 
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Unaffected to 14.9 in Mild to 14.4 in Moderate to 12.8 in Severe (p < 0.001). The mean age 
of first regular drinking progresses from 18.8 in Unaffected to 17.5 in Mild to 16.9 in 
Moderate to 15.7 in Severe (p < 0.001). The mean age for meeting criteria for Mild AUD 
progresses from 18.6 in Mild to 17.4 in Moderate to 16.1 in Severe (p < 0.001). The mean 
age for meeting criteria for Moderate AUD progresses from 19.1 in Moderate to 17.3 in 
Severe (p < 0.001). The age of onset for Severe AUD is 18.5. This age relationship is 
detailed in Figure 3.
Figure 3 represents the onset of alcohol use and alcohol problems in 3286 adolescents 
observed over a ten year period. It includes 1870 who remained unaffected, 684 who 
developed mild alcohol use disorder, 415 who developed moderate alcohol use disorder, and 
317 who developed severe alcohol use disorder.
The ANOVA for onset of first drink among the unaffected, mild, moderate, and severe 
cohorts shows p < 0.001. The ANOVA for onset of regular drinking among the unaffected, 
mild, moderate, and severe cohorts shows p < 0.001. The ANOVA for onset age of mild 
AUD among the mild, moderate, and severe cohorts shows p < 0.001. The t-test for onset 
age of moderate AUD between the moderate and severe cohorts shows p < 0.001.
DISCUSSION
These data suggest a strong effect of externalizing and internalizing disorders on prevalence 
and age of onset of Alcohol Use Disorder among adolescents/young adults at risk for the 
development of AUD on the basis of family history. Externalizing disorders were clearly 
associated with an increased risk for AUD and for earlier development of AUD. 
Internalizing disorders by themselves did not show a significant effect, but in combination 
with externalizing disorders they were associated with an earlier onset for severe AUD (in 
comparison to externalizing disorders alone). When we considered all internalizing disorders 
together (with or without externalizing disorders) a clear effect on onset of moderate AUD 
was seen as well. By the end of the follow-up period, more than 60% of young people with 
both externalizing and internalizing disorders at baseline had developed alcohol dependence 
in comparison with about 30% of young people with neither type of comorbid disorder. The 
effect of comorbidity was stronger in more severe forms of AUD, with a 6-fold increase in 
risk for Severe AUD among subjects with both externalizing and internalizing disorders 
compared to subjects with neither form of comorbid disorder.
There was also evidence for an earlier developmental course in more severe forms of AUD 
compared to less severe. Persons with Severe AUD were likely to have their first full drink 
prior to the age of 13 and be drinking regularly prior to age 16 and experiencing 1–2 alcohol 
problems by that same age. In contrast young people who did not demonstrate any AUD 
were likely to have their first drink at 16 and start regular drinking just prior to age 19. 
Median and mean ages of onset for each type of AUD were 18–19, though the range 
extended through the follow-up period.
Those at greatest risk for an AUD were males of European descent from an alcohol-
dependent proband family with one or more childhood onset psychiatric diagnoses. Those at 
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least risk were females of African-American ancestry from a non-case family with no 
childhood onset diagnosis.
Limitations of the study include the fact that all analyses are based on self-report and there is 
no independent corroboration of diagnoses or symptoms. Subjects interviewed in their late 
20s may have had more difficulty with accurate reporting of events in early teenage years in 
comparison to subjects in their mid-teens. Retention rate from baseline interview to two-year 
interview was 85%, the majority of subjects completed at least four interviews ([23] Bucholz 
et al., 2017). Families in the COGA study tend to be densely affected and results may not be 
generalizable to persons with alcohol use disorder in the general population. The subjects 
were ascertained at 7 University-based clinical sites (State University of New York, 
Brooklyn, University of Iowa, Iowa City, Indiana University School of Medicine, 
Indianapolis, Washington University in St. Louis, University of California San Diego, 
University of Connecticut, Hartford, and Howard University, Washington DC) and the 
populations studied reflect those sites.
The magnitude of these effects was substantial, and this information may be helpful in 
targeting efforts at education and prevention. In this sample most of the AUD-affected 
subjects had a comorbid psychiatric disorder at baseline. Many such subjects may come to 
clinical attention for their childhood-onset disorders and it may be worth educational efforts 
targeting AUD, especially for those at increased familial risk. It has been argued, though, 
that more intensive interventions are not likely to be cost- effective at this time ([13] Glantz 
et al., 2009). It seems to be of value to continue to try to quantify risk in various clinically 
and biologically identifiable groups. Polygenic risk scores, especially as they increase in 
power with data from expanding clinical samples, will likely be of use ([31] Fullerton and 
Nurnberger, 2019). It would also be of value to attempt to separate AUD effects from other 
forms of SUD, since we know that they are highly comorbid in many samples, including the 
sample studied here.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
(a) Kaplan-Meier Plot by Prior Comorbidity—Mild AUD. (b) Kaplan-Meier Plot by Prior 
Comorbidity—Moderate AUD. (c) Kaplan-Meier Plot by Prior Comorbidity—Severe AUD. 
Numbers in the Figure represent the N of subjects at risk at various ages.
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Figure 2. 
(a)Age of onset for drinking milestones in Mild AUD. (b) Age of onset for drinking 
milestones in Moderate AUD. (c) Age of onset of drinking milestones in Severe AUD.
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Figure 3. 
Comparison of drinking milestones in four groups divided by severity of alcohol problems.
Nurnberger et al. Page 15
J Psychiatr Brain Sci. Author manuscript; available in PMC 2019 December 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Nurnberger et al. Page 16
Table 1.
Baseline characteristics (N = 3286).
Subject Variable Mean (SD)
Age at first interview 16.13 (3.29)
Age at last interview 23.13 (4.97)
Number of interviews 4.02 (1.73)
Gender
 Female 1673 (50.91%)
 Male 1613 (49.09%)
Ethnicity
 EA 2133 (64.91%)
 AA 1016 (30.92%)
 Other 155 (4.21%)
Family type
 Case 2848 (86.67%)
 Control 438 (13.33%)
Any type of AUD
 Yes 1416 (43.09%)
 No 1870 (56.91%)
Comorbidity
 Externalizing only 982 (29.88%)
 Internalizing only 140 (4.26%)
 Both 286 (8.70%)
 Neither 1878 (57.15%)
J Psychiatr Brain Sci. Author manuscript; available in PMC 2019 December 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Nurnberger et al. Page 17
Table 2.
Hazard ratio and 95% CI-Cox model.
Comorbidity Outcome Description HR (95% CI)
Comorbidity at baseline Onset age of mild AUD Gender: Female vs Male 0.71 (0.61, 0.83)
Ethnicity: African American vs European American 0.65 (0.55, 0.77)
Ethnicity: African American vs Other 1.11 (0.68, 1.79)
Ethnicity: European American vs Other 1.69 (1.06, 2.71)
Family type: Control vs Case 0.74 (0.59, 0.93)
Comorbidity at baseline: Both vs External 0.89 (0.65, 1.21)
Comorbidity at baseline: Both vs Internal 1.35 (0.86, 2.10)
Comorbidity at baseline: Both vs Neither 1.39 (1.04, 1.87)
Comorbidity at baseline: External vs Internal 1.51 (1.04, 2.20)
Comorbidity at baseline: External vs Neither 1.57 (1.33, 1.85)
Comorbidity at baseline: Internal vs Neither 1.04 (0.72, 1.49)
Onset age of moderate AUD Gender: Female vs Male 0.61 (0.50, 0.75)
Ethnicity: African American vs European American 0.45 (0.35, 0.57)
Ethnicity: African American vs Other 0.43 (0.27, 0.70)
Ethnicity: European American vs Other 0.97 (0.62, 1.51)
Family type: Control vs Case 0.38 (0.25, 0.56)
Comorbidity at baseline: Both vs External 1.32 (0.97, 1.79)
Comorbidity at baseline: Both vs Internal 1.84 (1.15, 2.95)
Comorbidity at baseline: Both vs Neither 2.80 (2.07, 3.77)
Comorbidity at baseline: External vs Internal 1.39 (0.91, 2.14)
Comorbidity at baseline: External vs Neither 2.12 (1.70, 2.64)
Comorbidity at baseline: Internal vs Neither 1.52 (1.00, 2.31)
Comorbidity at baseline Onset age of severe AUD Gender: Female vs Male 0.70 (0.56, 0.88)
Ethnicity: African American vs European American 0.37 (0.28, 0.49)
Ethnicity: African American vs Other 0.23 (0.14, 0.36)
Ethnicity: European American vs Other 0.62 (0.41, 0.94)
Family type: Control vs Case 0.32 (0.19, 0.52)
Comorbidity at baseline: Both vs External 1.88 (1.41, 2.51)
Comorbidity at baseline: Both vs Internal 6.01 (3.00, 12.04)
Comorbidity at baseline: Both vs Neither 6.08 (4.51, 8.21)
Comorbidity at baseline: External vs Internal 3.20 (1.62, 6.32)
Comorbidity at baseline: External vs Neither 3.24 (2.49, 4.21)
Comorbidity at baseline: Internal vs Neither 1.01 (0.51, 2.00)
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